Lowenstein Sandler represented Pomelo Care, a virtual medical practice that improves maternal and newborn health outcomes, increases access to care, and reduces avoidable costs, in a $46 million in Series B financing led by existing investors First Round Capital and Andreessen Horowitz (a16z) Bio + Health. Pomelo will use this funding to accelerate its partnerships with payors across the country to address the root causes of the maternal health crisis.
1 in 10 babies born in the U.S. today start their life in a neonatal intensive care unit. U.S., maternal morbidity and mortality rates are higher than peer countries, and the disparities in outcomes for people of color are unacceptable. Healthcare access continues to worsen, with 1 in 8 births occurring in U.S. counties with limited-to-no access to maternal care. Due to significant gaps in postpartum care, about half of pregnancy-related deaths in the U.S. occur after hospital discharge.
Pomelo has developed a care model that addresses these challenges by analyzing claims and health record data to proactively identify individual risk factors and providing virtual pregnancy, postpartum, and infant care to patients nationwide to reduce those risks, dramatically increasing access to high-quality, evidence-based care and improving outcomes.
In 2023, Lowenstein Sandler represented Pomelo Care in a $33 million Seed and Series A fund raise led by Andreessen Horowitz.
The Lowenstein deal team included Eric Weiner, Ed Zimmerman, Laura Cicirelli, Frank Eucalitto, Claire Dronzek, Erich J. Kaletka, and Eric Sands.
